BLU Insider Trading (BELLUS Health)
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$0.00
Insider Selling (Last 12 Months): C$118,989.56
BELLUS Health Share Price & Price History
Current Price: C$15.11
Price Change: ▲ Price Increase of +0.58 (3.99%)
As of 08/12/2022 01:00 AM ET
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.
And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
BELLUS Health Insider Trading History
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|3/22/2022||Francois Desjardins||Senior Officer||Sell||14,053||C$8.47||C$118,989.56||81,722|
|6/10/2020||Orbimed Advisors LLC ||Insider||Sell||36,400||C$14.08||C$512,657.60||1,182,416|
Average 126% gains – NO losers!?
An epic crash is all but inevitable, but these dark times can offer staggering opportunities.
Today, Dr. Martin Weiss reveals "Crash Profit Trades" that could have produced average gains of 126% even when stocks tumbled.
All with NO losing trades!
Click Here to Discover the Secret.
SEC Filings (Institutional Ownership Changes) for BELLUS Health (TSE:BLU)
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. The company was incorporated in 1993 and is based in Laval, Canada.
50 Day Range
52 Week Range
Who are the company insiders with the largest holdings of BELLUS Health?